Generic Medicine Info
Known or suspected susceptibility to malignant hyperthermia, raised CSF pressure, history of unexplained jaundice or acute hepatic damage from previous exposure to halothane. Childn <18 yr undergoing outpatient dental surgery.
Special Precautions
Patient w/ phaeochromocytoma, myasthenia gravis, renal failure, pre-existing hepatic disease. Childn. Pregnancy and lactation. Patient Counselling May impair ability to drive or operate machinery. Monitoring Parameters Monitor pulse and BP.
Adverse Reactions
Post-op nausea, vomiting, and shivering; resp depression, hypotension, skeletal muscle relaxation, bradycardia.
Potentially Fatal: Hepatotoxicity, malignant hyperthermia, cardiac arrhythmias.
Drug Interactions
Increased risk of ventricular dysrhythmias w/ epinephrine. Increased risk of malignant hyperthermia w/ suxamethonium. Prolonged recovery from anaesth w/ concurrent use of ketamine for induction. May potentiate response to non-depolarising muscle relaxants, hypotensive agents (e.g. hexamethonium bromide, trimetaphan camsilate).
ATC Classification
N01AB01 - halothane ; Belongs to the class of halogenated hydrocarbons. Used as general anesthetics.
Disclaimer: This information is independently developed by CIMS based on halothane from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in